Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysisLuca Arecco, Matteo Lambertini, M. Condorelli et al.|Human Reproduction|2022Cited by 105
Health-related quality of life in cancer patients treated with immune checkpoint inhibitors in randomised controlled trials: A systematic review and meta-analysisAndrea Boutros, Francesco Spagnolo, Marco Bruzzone et al.|European Journal of Cancer|2021Cited by 42
Activity and safety of first-line treatments for advanced melanoma: A network meta-analysisAndrea Boutros, Francesco Spagnolo, Enrica T. Tanda et al.|European Journal of Cancer|2023Cited by 38
Dose‐dense adjuvant chemotherapy in HER2‐positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trialMatteo Lambertini, Francesca Poggio, Marco Bruzzone et al.|International Journal of Cancer|2019Cited by 20
Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancerFabio Puglisi, Lucia Del Mastro, Lorenzo Gerratana et al.|npj Breast Cancer|2021Cited by 9